Paolo Fabio Fiumara Selected Research

Azacitidine (5 Azacytidine)

1/2021

Off-Label Use of Venetoclax in Patients With Acute Myeloid Leukemia: Single Center Experience and Data From Pharmacovigilance Database.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paolo Fabio Fiumara Research Topics

Disease

3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2023 - 01/2021
2	Neoplasms (Cancer) 01/2023 - 02/2022
1	Acute Kidney Injury (Acute Renal Failure) 05/2023
1	Digestive System Diseases 05/2023
1	Hemorrhage 05/2023
1	Residual Neoplasm 01/2023
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023
1	Myeloid Sarcoma (Chloroma) 04/2022
1	Chromosome Aberrations (Chromosome Abnormalities) 02/2022
1	Eosinophilia 02/2022
1	Fever (Fevers) 01/2021
1	Infections 12/2011

Drug/Important Bio-Agent (IBA)

2	gilteritinibIBA 05/2023 - 04/2022
1	blinatumomabIBA 01/2023
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 02/2022
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 02/2022
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 02/2022
1	Decitabine FDA Link 01/2021
1	venetoclaxIBA 01/2021
1	Azacitidine (5 Azacytidine)FDA Link 01/2021
1	Rituximab (Mabthera)FDA Link 12/2011

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2021 - 12/2011
1	Therapeutics 04/2022
1	Off-Label Use 01/2021